Immutep Limited (PRRUF)
USD 0.2
(-26.74%)
USD 0.2
(-26.74%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -34.82 Million | -35.35 Million | -30.22 Million | -17.64 Million | -10.83 Million | -15.28 Million |
| Net Income | -42.71 Million | -39.89 Million | -32.21 Million | -29.9 Million | -13.46 Million | -18.34 Million |
| Depreciation & Amortization | 2.26 Million | 2.06 Million | 2.06 Million | 2.07 Million | 2.07 Million | 1.87 Million |
| Deferred income taxes | - | -4.46 Million | -332.77 Thousand | -7.29 Million | -6.1 Million | -5.7 Million |
| Stock-based compensation | 1.79 Million | 2 Million | 2.16 Million | 1.7 Million | 1.72 Million | 1.58 Million |
| Change in working capital | 3.45 Million | 764.59 Thousand | -1.56 Million | -1.99 Million | 94.16 Thousand | -345.18 Thousand |
| Other non-cash items | 379.86 Thousand | 4.17 Million | 324.73 Thousand | 17.77 Million | 4.83 Million | 5.64 Million |
| Investing Cash Flow | -21.01 Million | -82.73 Thousand | -22.91 Thousand | -15.6 Thousand | -19.34 Thousand | -41.43 Thousand |
| Investments in PPE | -932.36 Thousand | -82.73 Thousand | -22.91 Thousand | -15.6 Thousand | -19.34 Thousand | -41.43 Thousand |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | -20.08 Million | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | -903.15 Thousand | - | -23 Thousand | -7000.00 | - | - |
| Financing Cash Flow | 95.18 Million | 76.02 Million | 50.32 Million | 52.67 Million | 20.47 Million | 8.01 Million |
| Debt repayment | -226.49 Thousand | -211.97 Thousand | -222.53 Thousand | -214.37 Thousand | -77.54 Thousand | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 100.23 Million | 76.23 Million | 52.97 Million | 43.3 Million | 22.03 Million | 4.87 Million |
| Other Financing Activities | -4.82 Million | -3.84 Million | -2.42 Million | 9.58 Million | -1.47 Million | 3.14 Million |
| Accounts receivables | 601.76 Thousand | -1.6 Million | -2.24 Million | -2.83 Million | 1.9 Million | -1.76 Million |
| Accounts payables | 537.56 Thousand | 3.27 Million | 1.43 Million | 1.38 Million | -2.12 Million | 1.39 Million |
| Inventory | - | - | 813.91 Thousand | - | - | - |
| Other working capital | 2.85 Million | -900.11 Thousand | -1.56 Million | -543.41 Thousand | 319.73 Thousand | 20.42 Thousand |
| Cash at beginning of period | 123.41 Million | 79.99 Million | 60.59 Million | 26.32 Million | 16.56 Million | 23.47 Million |
| Cash at end of period | 161.79 Million | 123.41 Million | 79.99 Million | 60.59 Million | 26.32 Million | 16.56 Million |
| Capital Expenditure | -932.36 Thousand | -82.73 Thousand | -22.91 Thousand | -15.6 Thousand | -19.34 Thousand | -41.43 Thousand |
| Effect of forex changes on cash | -967.73 Thousand | 2.83 Million | -671.03 Thousand | -752.83 Thousand | 134.67 Thousand | 407.57 Thousand |
| Net cash flow / Change in cash | 38.37 Million | 43.42 Million | 19.4 Million | 34.27 Million | 9.75 Million | -6.9 Million |
| Free Cash Flow | -35.75 Million | -35.43 Million | -30.25 Million | -17.65 Million | -10.85 Million | -15.32 Million |
| Breakdown | 2024 Q4 | 2024 FY | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -21.48 Million | -42.71 Million | - | -21.22 Million | - | -19.27 Million |
| Depreciation & Amortization | 2.26 Million | 2.26 Million | - | 995.78 Thousand | - | 924.01 Thousand |
| Deferred income taxes | - | - | - | - | - | -2.24 Million |
| Stock-based compensation | 794.07 Thousand | - | - | 1 Million | - | 2 Million |
| Change in working capital | 3.45 Million | 3.99 Million | - | - | - | -1.6 Million |
| Other non-cash items | -1.39 Million | 5.02 Million | - | 779.75 Thousand | - | -3.24 Million |
| Investing Cash Flow | -20.02 Million | -21.01 Million | -559 Thousand | -419.12 Thousand | -338 Thousand | -23.52 Thousand |
| Investments in PPE | -49.36 Thousand | -932.36 Thousand | -538 Thousand | -332.81 Thousand | -338 Thousand | -7328.00 |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | -20 Million | -20.08 Million | - | -86.3 Thousand | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | -19.15 Thousand | - | -21 Thousand | -402.3 Thousand | - | -16.2 Thousand |
| Financing Cash Flow | 95.66 Million | 95.18 Million | -55 Thousand | -431.85 Thousand | -360 Thousand | 76.13 Million |
| Debt repayment | -31.49 Thousand | - | -55 Thousand | -69 Thousand | - | -61.97 Thousand |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 95.64 Million | 95.35 Million | - | -296.26 Thousand | - | 76.23 Million |
| Other Financing Activities | 95.69 Million | 54.49 Thousand | 14.04 Thousand | -66.59 Thousand | -360 Thousand | -35.81 Thousand |
| Accounts receivables | 601.76 Thousand | 601.76 Thousand | - | - | - | -1.6 Million |
| Accounts payables | - | 537.56 Thousand | - | - | - | - |
| Inventory | - | - | - | - | - | - |
| Other working capital | 2.85 Million | 2.85 Million | - | - | - | -900.11 Thousand |
| Cash at beginning of period | 95.41 Million | 123.41 Million | 103.73 Million | 123.41 Million | 123.41 Million | 68.37 Million |
| Cash at end of period | 161.79 Million | 161.79 Million | 95.41 Million | 103.73 Million | 110.14 Million | 123.41 Million |
| Capital Expenditure | -49.36 Thousand | -932.36 Thousand | -538 Thousand | -332.81 Thousand | -338 Thousand | -7328.00 |
| Effect of forex changes on cash | -1.76 Million | - | 1.28 Million | -758 Thousand | 279 Thousand | -80.89 Thousand |
| Net cash flow / Change in cash | 66.37 Million | 38.37 Million | -8.32 Million | -19.68 Million | -13.27 Million | 55.04 Million |
| Free Cash Flow | -16.42 Million | -35.75 Million | -538 Thousand | -18.78 Million | -13.19 Million | -23.44 Million |
0H68
BRVVF
PFOCUS
ARCAY
QNNTF
0LO3